医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Final Countdown to World’s Largest Integrated Healthcare Industry Event tHIS

2015年05月06日 PM09:00
このエントリーをはてなブックマークに追加


 

SHANGHAI

With only days to go to the grand launch of The Health Industry Summit (tHIS) in Shanghai, China, the excitement and anticipation is building up to what is the largest health industry event in the world this year. More than 200,000 professionals are ready to travel from 140 countries and all corners of China to attend the event on May 15-18, 2015 at the brand new National Exhibition & Convention Center (NECC), Shanghai.

Themed “where the world of Pharmaceutical and Medical industries converge”, this mega event is expected to turn a new chapter in the healthcare industry in China.

tHIS, to cover more than 280,000sqm, is the first B2B event to employ all halls of NECC (Shanghai). Among the highlights of the Summit is the premier investment conference – Healthcare China 2015, a top-level 2-day program focused on the investment in healthcare in and out of China. Keynote speakers include Li Jian’ge, Director of Tsinghua PBCSF and He Wei, Deputy Chairman of Chinese Peasants and Workers Democratic Party Central Committee, among a long list of CEOs and government officials that are set to kick off the next wave of investments and collaboration into the health sector. Engaging topics include Strategic Layout for China Greater Healthcare Industry Platform, Medical system reform and innovation in the Internet+ era and much more.

Beyond the sold-out segments of Medical Equipment, Drug Formulation, Pharmaceutical Ingredients and Manufacturing Technology represented by industry leading member events like CMEF, PHARMCHINA and API CHINA, newly-launched shows and segments are also under the spotlight. – Natural Health and Nutrition China and Logistics Pavilion within PHARMCHINA.

Along with over 10,000 international buyers and delegates from more than 140 countries and regions, pavilions will gather exhibitors from more than 20 regions and nations including USA, Germany, UK, France, India, Israel, Italy, Japan, Korea, Malaysia, Netherlands, Poland, Singapore, Switzerland, Taiwan, Austria, Australia, Belgium, Canada, and Hong Kong. Experts in the industry anticipate that this is only the beginning for the show and China. With a clear government backing to develop the healthcare segment and colossal shift in investment to fuel the boom, the Summit will expand and play a greater role in global trading, technology and knowledge exchange of the healthcare sector.

CONTACT

Reed Sinopharm Exhibitions
Sophie Zhang, +86-10-84556580
jing.zhang@reedsinopharm.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表
  • Intercell USA Changes Name to Valneva USA, Inc. and Expands Commercial Presence
  • ADC Therapeutics präsentiert Zwischenergebnisse aus Phase-I-Studie zu neuartigem Antikörper-Wirkstoff-Konjugat ADCT-402
  • Bertin与Zymo Research宣布达成新的合作